Safety and Feasibility of Fasting While Receiving Chemotherapy
This study has been completed.
Sponsor:
King Fahad Medical City
Information provided by:
King Fahad Medical City
ClinicalTrials.gov Identifier:
NCT00757094
First received: September 19, 2008
Last updated: February 24, 2010
Last verified: February 2010
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 19, 2008 | ||||
| Last Updated Date | February 24, 2010 | ||||
| Start Date ICMJE | September 2008 | ||||
| Primary Completion Date | December 2008 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Safety of fasting while receiving chemotherapy [ Time Frame: two months ] [ Designated as safety issue: Yes ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT00757094 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
Effect of fasting on chemotherapy side effects [ Time Frame: two months ] [ Designated as safety issue: No ] | ||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | |||||
| Original Other Outcome Measures ICMJE | |||||
| Descriptive Information | |||||
| Brief Title ICMJE | Safety and Feasibility of Fasting While Receiving Chemotherapy | ||||
| Official Title ICMJE | Safety and Feasibility of Fasting While Receiving Chemotherapy | ||||
| Brief Summary | Fasting (refraining from eating and drinking) during the day is safe while receiving chemotherapy. |
||||
| Detailed Description | |||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case-Crossover Time Perspective: Prospective |
||||
| Biospecimen | |||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Fasting patients who are schedulled to receive chemotherapy during the month of Ramadan |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | |||||
| Study Group/Cohort (s) | I
Patients planning to observe fasting while receiving chemotherapy during the month of Ramadan |
||||
| Publications * |
|
||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 12 | ||||
| Completion Date | March 2009 | ||||
| Primary Completion Date | December 2008 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Saudi Arabia | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00757094 | ||||
| Other Study ID Numbers ICMJE | KFMC IRB-08-040 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Ali Al-Shanqeeti, King Fahad Medical City | ||||
| Study Sponsor ICMJE | King Fahad Medical City | ||||
| Collaborators ICMJE | |||||
| Investigators ICMJE |
|
||||
| Information Provided By | King Fahad Medical City | ||||
| Verification Date | February 2010 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||
